Conferences and Meetings on Pharmacology and Drug Development

Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.

ALL COUNTRIES

1.
 
Keystone Symposia: Biobetters and Next-Generation Biologics: Innovative Strategies for Optimally Effective Therapies
ID
830117
Dates
22 Jan 2017 - 26 Jan 2017
Location
Snowbird, Utah, United States
Abstract
The purpose of this meeting is to examine different approaches for treatment of cancer and other diseases (e.g., fibrosis, autoimmunity and inflammatory diseases). The program will provide insights from academic and industry scientists on innovative biologics technologies and treatment strategies for ameliorating disease in an effort to identify synergies and opportunities to cross-fertilize approaches. Furthermore, the meeting includes perspectives from the US Food & Drug Administration and how the outlined strategies will impact the drug review and approval process. The intention is to better inform meeting attendees of current/future strategies for treating disease and best practices for transforming concepts into approved drugs.
Contact
Attendee Services;     Phone: [970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
Cancer, drug discovery, immunology
2.
 
Drug Development, Pharmacokinetics and Imaging
ID
828828
Dates
23 Jan 2017 - 27 Jan 2017
Location
Oxford, United Kingdom
Abstract
The Drug Development, Pharmacokinetics and Imaging module is a one-week module of the MSc in Experimental Therapeutics programme. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the module will be led by Dr Paul Brennan, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Contact
Course Administrator;     Phone: [+44(0) 01865 286955];     Email: expther@conted.ox.ac.uk
3.
 
FDA Scrutiny of Promotion and Advertising Practices
ID
852500
Dates
24 Jan 2017 - 25 Jan 2017
Location
San Francisco, United States
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
fda's advertising and promotion requirements, fda regulations for labelling, fda warning letter, fda legal authority, ftc, mass media, doj, off label, fda guidance, custom device promotion, fda compliance seminar
4.
 
Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions
ID
855364
Dates
26 Jan 2017 - 27 Jan 2017
Location
Orlando, United States
Abstract
Raw material requirements in a cGMP environment are often overlooked as a company develops new products. Depending on the product being developed, e.g., tablets and capsules vs. biotechnology products, as few as fifteen to twenty or as many as sixty raw materials need to be sourced before the process can be moved from initiation through completion.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Raw material requirements in a cgmp environment training, compendial and non-compendial testing, ASQ on sample size, ICH Q9
5.
 
Latin America: Regulatory Compliance Requirements for Life Science Products (Focus: Brazil, Mexico, Argentina)
ID
855374
Dates
26 Jan 2017 - 27 Jan 2017
Location
San Francisco, United States
Abstract
This two-day comprehensive Course on Latin America Regulatory compliance requirements will cover topics ranging from pre-clinical and clinical requirements through product registration, amendments and renewals across Pharmaceuticals, Biologics, Medical Devices and Combination Products. The Course will address the structure of the regulatory agencies in Latin America and discuss local cultural nuances to help you be successful in working with the regulators.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Latin America regulations, Latin America life sciences regulations, Latam life sciences regulatory requirements, Latin America pharmaceutical regulations, Latin America medical device regulations, Latin America biologics regulations
6.
 
Supplier and Contractor Qualification and Control for Life Science Industry
ID
855362
Dates
26 Jan 2017 - 27 Jan 2017
Location
Tampa, United States
Abstract
This two-day course focuses on the processes associated with the acquisition of products, materials and services that fuel and support the organization’s product manufacturing and marketing. These cross-functional processes are complex and result in conflicting objectives between decision-makers. Management is responsible for organizing and providing resources and the more they understand, the more effectively they can manage. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Supplier control program, contractor qualification, Part 211, subpart e-control, drug product containers, ICH Q7A, section VII, materials management part 820
7.
 
Essentials Of USP Microbiology - Reading Between the Lines of the USP General and Information Microbiology Chapters
ID
855394
Dates
31 Jan 2017 - 01 Feb 2017
Location
Orlando, United States
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
USP Microbiology, USP microbiology chapters, USP general, USP General Chapter Changes, USP Chapters, USP document, HVAC, USP, EP and JP
8.
 
Navigating the Maze for Post-Market Compliance -- Complaint Handling, MDRs, Recalls and Proposed Guidance on FDA Risk Benefits
ID
868074
Dates
02 Feb 2017 - 03 Feb 2017
Location
Tampa, United States
Abstract
This interactive one and a half day course led by Ms. Rita Hoffman, Former FDA CDRH Recall Branch Chief, who has more than 36 years’ experience with the FDA will provide the participants tools to minimize risk of regulatory enforcement actions.

During the seminar, Ms. Hoffman will explain proper handling of complaints reportable or non-reportable, product complaint handling and documentation, how and when to file Medical Device Reports (MDR), effective and appropriate communication with the appropriate regulatory agencies in the event of a recall. She will also discuss how to conduct a correction and removal actions to avoid a recall crisis, including required recordkeeping, expectation from FDA and other regulatory agencies in the event of a recall and key factors in implementing and maintaining compliance with the regulations and real life experiences of FDA.Note:Use coupon code NB5SQH8N and get 10% off on registration.

Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
medical device recalls seminar, medical device regulations seminar, medical device reporting, medical device complaint management, medical device complaint handling
9.
 
Compliance Risk Management in Medical Devices, Pharmaceuticals, and Combination Products
ID
868095
Dates
02 Feb 2017 - 03 Feb 2017
Location
Tampa, United States
Abstract
Effective risk management is the hallmark of a successful corporation. Increasingly, it is also the hallmark of a compliant corporation. While Medical Devices, Pharmaceuticals, and Combination Products have had unique histories for the evolution of risk management, the management of compliance risk is a common business process for all three areas.Enterprise Risk Management (ERM) is the generic term for managing the risks of an organization. ISO 31000 is the ERM ISO Standard. This standard provides guidance for organizations on implementing ERM solutions. ISO 9001 is the Quality Systeme Standard. ISO 9001 now requires to establish “risk-based thinking.” As a result, ISO 13485, the International Quality System Standard for Medical Devices, has been revised to include requirements for firms to implement Compliance Risk Management. These requirements are in addition to the requirements as currently defined by ISO 14971, the International Standard for Risk Management of Medical Devices.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Enterprise Risk Management (ERM) Training, ISO 31000, ERM solutions, ISO 14971 Training, medical device risk management training
10.
 
9ITIM — 9th Immunotherapeutics & Immunomonitoring Conference
ID
854204
Dates
06 Feb 2017 - 07 Feb 2017
Location
San Diego, United States
Abstract
GTCbio is proud to present the 9th Immunotherapeutics & Immunomonitoring Conference, to be held on February 6-7, 2017 in San Diego, CA.
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
Topics
Immunotherapy, Immune therapeutics. Immunotherapeutics, Immunomonitoring, Immunodiagnostics
11.
 
Chemical Development Scale-Up in the Fine Chemical and Pharmaceutical Industries
ID
858689
Dates
06 Feb 2017 - 08 Feb 2017
Location
Mumbai, India
12.
 
7th Ubiquitin Research & Drug Discovery Conference
ID
855591
Dates
08 Feb 2017 - 09 Feb 2017
Location
San Diego, United States
Abstract
We are pleased to invite you to GTCbio's 7th Ubiquitin Research & Drug Discovery Conference, which will take place February 8-9, 2017 in San Diego, CA. This conference will provide a forum for researchers from industry and academia to learn about recent advances in basic science and drugs that target the ubiquitin/proteasome system. Hot topics such as autophagy in cancer, developments with deubiquitinating enzymes, and novel drug targets in the ubiquitin system will be covered. Please join us not only for updates on the latest scientific research, but also for networking sessions between colleagues from both industry and academia in order to get the most comprehensive exchange of ideas.
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
13.
 
3rd Protease Inhibitors in Drug Discovery Conference
ID
855645
Dates
08 Feb 2017 - 09 Feb 2017
Location
San Diego, United States
Abstract
We are pleased to announce the 3rd Protease Inhibitors in Drug Discovery Conference, to be hosted by GTCbio on February 8-9, 2017 in San Diego, CA. Though protease inhibitors hold great therapeutic promise in areas such as inflammation, cardiovascular diseases, and cancer, researchers in the field are still overcoming the challenge of specificity for drug design. This meeting will provide a forum for scientists from both industry and academia to share recent advances in protease inhibitor research, from biological functions to translational aspects for drug discovery. Speakers will cover topics such as regulation of proteases by exosites, drug design of protease inhibitors, membrane-associated proteolysis, and many more. In addition to cutting-edge scientific presentations, attendees will be able to form new connections during dedicated networking sessions.
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
14.
 
SOPs for FDA-Regulated Industry: Best Practices to Withstand FDA Expectations
ID
868061
Dates
09 Feb 2017 - 10 Feb 2017
Location
Scottsdale, United States
Abstract
One of the best ways to ensure that an organization meets its regulatory obligations is to follow SOPs. SOPs are standardized procedures and processes prepared with enough detail to ensure that tasks are performed consistently each time they are done. SOPs are also required to be in compliance with regulations and guidelines internationally, across all regulated functions. Lack of SOPs and not following SOPs are often cited in regulatory inspections as deficiencies that must be corrected. Poorly prepared SOPs or poor compliance with existing SOPs can compromise a drug development program, an effective quality system, and may result in product recalls.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
FDA SOP requirements, FDA SOPs, FDA regulated industry SOP types, FDA SOP components, SOP training, SOP implementation, SOP template, SOP numbering system
15.
 
Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH)
ID
868082
Dates
09 Feb 2017 - 10 Feb 2017
Location
Burlingame, United States
Abstract
Analytical methods and procedures should be validated to ensure reliability, consistency and accuracy of analytical data. Compendial methods should be verified to demonstrate the suitability of laboratories to successfully run the method and when methods are transferred between laboratories successful transfer should be demonstrated through testing. In case a laboratory wants to use an alternative method instead of a compendial method, equivalency of the alternative method to the compendial method should be demonstrated.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Laboratory compliance, Analytical methods, data, procedures, compendial methods, Method validation and transfer, equivalency testing, FDA inspection
16.
 
FDA Recalls - Before You Start, and After You Finish
ID
868114
Dates
09 Feb 2017 - 10 Feb 2017
Location
San Jose, United States
Abstract
FDA's recall authority and program launches you into a project of crisis management. You will learn how to establish a roadmap for conducting recalls. The knowledge you gain will sharpen your recall management decisions and strategy. You will learn how to use the FDA's health risk criteria so you can develop effective recall procedures. One critical aspect of recalls involves the identification of the root cause of the recall and how you could or should prevent that problem from happening again. Your corrective and preventive action program (CAPA) and quality assurance functions require a rigorous approach to prevent a chronic history of recalls. Reiterative recalls lead the FDA to the conclusion that,
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
FDA Recall, FDA recall classes, FDA recall guidance, FDA recall procedures, regulatory management, CAPA, FDA inspection, Recall Regulations
17.
 
11th ANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE
ID
843037
Dates
12 Feb 2017 - 14 Feb 2017
Location
San Diego, California, United States
Abstract
This didactic conference will educate scientists on the processes of translating basic research into novel therapies and will leave participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug.
Contact
Sara Classen;     Phone: [Tel: +1.212.901.8009];     Email: sclassen@alzdiscovery.org
Topics
Neurodegeneration, Drug discovery, CNS, Alzheimer’s Disease
18.
 
The 7th Annual World ADC Berlin Summit
ID
856393
Dates
14 Feb 2017 - 16 Feb 2017
Location
Berlin, Germany
19.
 
SBCADD`2017 — 9th National Symposium cum Workshop on “Recent Trends in Structural Bioinformatics and Computer Aided Drug Design”
ID
853093
Dates
14 Feb 2017 - 17 Feb 2017
Location
Karaikudi, India
Abstract
SBCADD’2017 would like to take this wonderful privilege to invite you all to the 9thNational Symposium cum Workshop” going to be held during February 14th – 17th 2017, on the theme of “Recent Trends in Structural Bioinformatics and Computer Aided Drug Design” seeks to continue the good synergy obtained in the previous edition, providing a discussion forum from scientists, researchers, students and industrials about the latest ideas and realizations in the foundations, theory, models and applications for interdisciplinary and multidisciplinary research encompassing disciplines of Structural Biology, Molecular Biology, Structural Bioinformatics, Computer Aided Drug Design and Pharmacogenomics. In recent years, Computational Biology and Medical Informatics have seen significant advances driven by computational techniques making Bioinformatics and Computational Biology among the most vibrant research areas that could accelerate translational research comprising of the development and discovery of drugs against combating diseases that could enhance the livelihood and life expectancy of the individuals. The aim of SBCADD’2017 is to create a friendly environment that could lead to the establishment or strengthening of scientific collaborations and exchanges among attendees, and therefore, participation at SBCADD’2017 would provide an excellent opportunity to keep up with the cutting-edge research in such enlivening topics mentioned above and to network with other members of our community. We cordially invite you to submit abstract and participate in Symposium cum Workshop.
Contact
Dr. Sanjeev Kumar Singh;     Phone: [+91 – 4565 - 223342];     Email: dbiconf@gmail.com
Topics
SBCADD'2107, Sanjeevslab, Dr. Sanjeev Kumar Singh, sanjeevslab.org, bioinfoau.org
20.
 
Biologistics World Asia 2017
ID
827176
Dates
15 Feb 2017 - 16 Feb 2017
Location
Singapore, Singapore
Abstract
Biologistics World Asia will be the MOST Targeted event in Asia that focuses on cold- chain logistics for biomedical products. Bioplogistics World Asia 2017 will be attended by decision makers from regional and international biopharmaceuticals and biotechnology firms, top CMOs and CROs, government organizations and key global and Asian regulators. It’s your one stop solution to reach out to Asia’s logistics and supply chain industry!
Contact
Andrew Darwitan;     Phone: [+65 3109 0156];     Email: andrew.darwitan@imapac.com
21.
 
Early Access Programmes & Compassionate Use in the EU
ID
854481
Start date
20 Feb 2017
Location
Düsseldorf, Meliá Düsseldorf, Germany
Abstract
This seminar provides you with a detailed overview of early access possibilities in the EU in general as well as in Germany, the UK, Spain and France in particular. After having attended the seminar, you will be aware of the available options for, and the arising challenges of, bringing your pharmaceuticals to the European market as fast as possible. Specifically, topics such as eligibility to the various programmes, data requirements and reimbursement options will be discussed in order to acquire a deep understanding of how patients could benefit from your products at the earliest possible.
Contact
Dr. Henriette Wolf-Klein;     Phone: [+49 6221 500-680];     Email: h.wolf-klein@forum-institut.de
Topics
medical affairs, market access, healthcare management, early access in the EU legal framework, compassionate use in France - ATU as best practice?, early access in the UK - the early access to medicines scheme, early access possibilities in Spain, the German compassionate use programme - lessons learnt
22.
 
Marketing Authorisation in Russia, Belarus, Kazakhstan and Ukraine
ID
854559
Dates
20 Feb 2017 - 21 Feb 2017
Location
Berlin, Mercure Hotel MOA Berlin, Germany
Abstract
Legislation for the registration and circulation of pharmaceutical products is changing significantly, under pressure from the planned Customs Union. This seminar provides you with in-depth knowledge on the current challenges when applying for a new marketing authorisation and an overview of maintenance activities in the EAEU countries. The regulatory framework in Ukraine, which is not an EAEU member state, will also be covered. After having attended the seminar you will know how to currently handle registration and distribution in Russia, Belarus, Kazakhstan and Ukraine, and which legislation changes are in progress.
Contact
Dr. Henriette Wolf-Klein;     Phone: [+49 6221 500-680];     Email: h.wolf-klein@forum-institut.de
Topics
Regulatory Affairs, distribution in EAEU countries, national registration in Belarus, Kazakhstan and Ukraine, EAEU - goals and timelines for implementation, local marketing authorisation in Russia, Marketing authorisation in the EAEU region, Maintenance duties
23.
 
World ADC Berlin — The 7th Annual World ADC Berlin
ID
845066
Dates
20 Feb 2017 - 22 Feb 2017
Location
Berlin, Germany
Contact
Jenny Barlow;     Phone: [+1 212 537 5898];     Email: info@hansonwade.com
Topics
Antibody drug conjugates, Antibody-drug conjugates, ADCs/ADC
Related subject(s)
24.
 
Vaccines-2017 — International Conference on Vaccines-2017
ID
811272
Dates
20 Feb 2017 - 22 Feb 2017
Location
Baltimore, United States
Abstract
This scientific conference will bring an opportunity to share potential benefits and limitations of vaccines in preventing and control of infectious and non-infectious diseases thereby enhancing the quality and longevity of life.Vaccines 2017 mainly showcases comprehensive approaches in Vaccines and research, virology. vaccine conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations
Contact
James Martin;     Phone: [1-302-231-6959];     Email: Vaccines@madrige.com
Topics
Vaccines, virology, Infectious and non infectious diseases, Therapeutic Medicines
25.
 
12th Annual Biomarkers Congress
ID
839687
Dates
21 Feb 2017 - 22 Feb 2017
Location
Manchester, United Kingdom
Abstract
Oxford Global is proud to present its 12th Annual Biomarkers Congress taking place on the 21-22 February 2017 in Manchester. Our renowned congress will bring together over 300 attendees, speakers and vendor companies from pharmaceutical and biotechnology companies as well as academia.

In line with the current industry trends, the flagship event this year focuses on the discovery, development and clinical development of biomarkers in Autoimmune, Immuno-oncology, Neuroscience, Oncology as well as Cardiovascular, Rheumatology, COPD, Rare Diseases and Microbiome. Our expert speakers will also cover innovations in Biomarker research such as imaging biomarkers and assay development, big data challenges in biomarker research, new advances in biomarker technologies and platforms; insights into the human proteome atlas, population genetics, systems biology and their implications in Biomarker development. Do not miss out on gaining insights on the role of biomarkers in clinical development, clinical trials and clinical diagnostics.

Contact
Danielle Dalby;     Phone: [+44 1865248455];     Email: d.dalby@oxfordglobal.co.uk
Topics
Clinical development, clinical trials, clinical diagnostics, innovative biology, microRNA’s, CTCs, liquid biopsies and free circulating RNA & DNA.
Related subject(s)
26.
 
DDRI — 3rd Drug Discovery Re-Invented (Emerging Role of Biotechs, Academics and Non-Profits)
ID
842995
Dates
21 Feb 2017 - 24 Feb 2017
Location
Cancun, Mexico
Contact
Jack Peters;     Phone: [01638 724137];     Email: jack@fusion-conferences.com
Topics
drugs, drug, drug discovery, pharma, pharmacology, research, pipelines, government, academic, non-profits, biotech, pharmaceutical, innovation, natural products, drug development, structure, modeling, approaches
27.
 
2nd Annual Lyotalk 2017 Asia — Pacific Largest conference in Freeze drying / Lyophilization
ID
852279
Dates
23 Feb 2017 - 24 Feb 2017
Location
HYDERABAD, India
Abstract
The event covers a wide spectrum from formulation, Development, Production, manufacturing and regulatory affairs topics such formulation strategies, Scale-up, cycle development & optimization, Regulatory compliance, Quality by Design (QbD) , PAT process design, Ice Nucleation, Case studies & troubleshooting, New developments in freeze drying, Process development for generics, proteins, biologics and vaccines.
Contact
Linda Clark;     Phone: [+912265344333];     Email: linda.clark@biotrains.com
Topics
The main topics will include • Formulation strategies • Scale-up, cycle development & optimization • Regulatory compliance • Quality by Design (QbD) • PAT process design, • Ice Nucleation • Case studies & troubleshooting • New developments in freeze drying • Process development for generics, proteins, biologics and vaccines.
28.
 
Frontiers in Cancer Immunotherapy
ID
824447
Dates
27 Feb 2017 - 28 Feb 2017
Location
New York, NY, United States
Abstract
This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. James Allison, Executive Director of the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center and a pioneer in the field of cancer immunotherapy, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including: the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.
Topics
Immunotherapy, Oncology, Immunology, Therapeutics, Clinical Trials, Vaccines, Diagnostics, Biomarkers, Genomics, Epigenomics, Epigenetics, Drug Discovery, Cancer
Related subject(s)
29.
 
Disposable Solutions for Biomanufacturing
ID
859637
Dates
27 Feb 2017 - 01 Mar 2017
Location
Munich, Germany
Abstract
By 2021 the knowledge and application of Single Use Systems will equal and even exceed that of Stainless Steel today. Where Disposable products and Single Use Technologies are becoming more widely used that ever before, this revolution has led to more questions than answers. In 2017, the 9th Annual event will bring you presentations from the main regulatory organisations plus panel discussions and case studies covering all aspects of disposables. Hear how to tackle all challenges from Particulates, Extractables and Leachables, System integrity, Implementation and more. This is the ONLY event that focuses on Single Use Technologies in biomanufacturing. For all your single use system questions, Disposable Solutions for Biomanufacturing Europe 2017 has the answers!
Contact
Rumina Akther;     Phone: [+44 (0)207 036 1300];     Email: enquire@iqpc.co.uk
Topics
Single use systems, SUS, disposables, bioreactors, standardization, CMO, Good Manufacturing Practice, GMP facility, extractables and leachables, BPOG, BPSA
30.
 
Chemical Development & Scale-Up in the Fine Chemical & Pharmaceutical Industries
ID
858622
Dates
01 Mar 2017 - 03 Mar 2017
Location
Pasadena, California, United States
31.
 
Seminar on the DHF, Technical File and Design Dossier - Similarities, Differences and the Future
ID
857612
Dates
02 Mar 2017 - 03 Mar 2017
Location
Las Vegas, NV, United States
Contact
Event Manager;     Phone: [(800) 447-9407];     Email: support@globalcompliancepanel.com
Topics
The Design History File, Device History Record, The Device Master Record, EU’s Medical Device Directive, Technical File Design Dossier, U.S. FDA’s DHF, FDA Compliance, FDA Regulations, Risk Analysis, Risk Management
32.
 
Keystone Symposia - Kinases: Next-Generation Insights and Approaches
ID
825333
Dates
05 Mar 2017 - 09 Mar 2017
Location
Breckenridge, Colorado, United States
Abstract
Decades of both basic and applied research have unequivocally established the importance the kinase family of phosphotransferase enzymes in virtually every aspect of organismal homeostasis. From the initial characterization of ATP-dependent phosphorylation in the liver by Gene Kennedy in 1954, our understanding of the family has grown from the diverse perspectives of enzymology, biochemistry, biophysics, structural biology, genetics, cellular biology, pharmacology and physiology. Importantly, these advancements have yielded transformative therapeutic approaches to disease, most notably in the field of cancer where kinase inhibition is helping to fulfill the promise of precision medicine. Yet even today, our perspectives on the complexity of this class of enzymes continues to evolve, and many of the most exciting advancements in the field are being made by applying modern-day insights and technological approaches to the diverse roles the enzymes can play in health and human disease. This meeting will be devoted to exploring this innovative leading edge of kinase research, and will bring together leading researchers from academic, clinical and pharmaceutical settings to explore and define the new horizons in the field of kinase biology.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
Kinases, Drug Discovery, Kinase Signaling, Kinase Inhibitor
33.
 
BB17 — 3rd Biologics & Biosimilars Congress
ID
855044
Dates
06 Mar 2017 - 07 Mar 2017
Location
Berlin, Germany
Abstract
This internationally respected congress is the networking meeting for those working in all areas of protein, antibody & biosimilar research. Executive panels and roundtables will foster discussion on the direction of the field, and the approaches required to ensure that the industry continues to flourish.
Contact
Jane Williams;     Phone: [01865 849841];     Email: jane@globalengage.co.uk
Topics
Life Sciences/Biology, Health Sciences, Pharma
Related subject(s)
34.
 
Pharmacodynamics, Biomarkers and Personalised Therapy
ID
828750
Dates
06 Mar 2017 - 10 Mar 2017
Location
Oxford, United Kingdom
Abstract
The Pharmacodynamics, Biomarkers and Personalised Therapy course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the week will be led by Dr Elaine Johnstone, Senior Research Fellow at the University of Oxford, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists, as well as a practical visit to one of Oxford's research laboratories.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
35.
 
Recunnect Ltd — 3rd Anti-Counterfeiting Pharma Conference 2017
ID
870614
Dates
07 Mar 2017 - 08 Mar 2017
Location
London, United Kingdom
Abstract
We welcome you to be a part of Recunnect’s 3nd Anti-Counterfeiting Pharma Conference 2017 showcasing the anti-counterfeiting strategies for a better informed decision making. The aim is to foster discussion on how to tackle counterfeiting and improve patient safety. Gain the best insight into the most pressing challenges through practical advice on streamlining procedures and practices in the industry.
Contact
Sarika Sareen;     Phone: [2071129183];     Email: marketing@recunnect.net
Topics
Drug, pharma, health, medicines,
36.
 
Pharmaceutica 2017 — 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
ID
833088
Dates
13 Mar 2017 - 15 Mar 2017
Location
London, United Kingdom
Abstract
Pharmaceutica 2017 provides the perfect platform for just this as an interactive and engaging 3-day event: unique in format, content, networking and engagement. The event brings together truly innovative thinkers who are leading the way through trialing new disruptive solutions and rethinking the conventional formulation and delivery mind-set and will help you to better understand how to develop the right formulation and delivery strategy with a strong scientific, clinical and commercial mind set and how innovative scientific techniques, emerging technologies and innovative devices can transform formulation and drug delivery.
Contact
Renaldo Howell;     Phone: [+1 702 508 5200];     Email: renaldohowell179@gmail.com
Topics
Pharmaceutics, Drug Delivery, Targeted Drug Delivery, Formulation, Pharmaceutical nanotechnology, nanomedicine, smart drug delivery
37.
 
Health Economics for Non-Health-Economists
ID
834385
Dates
16 Mar 2017 - 17 Mar 2017
Location
Brussels, Belgium
Abstract
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
38.
 
2nd Personalized Medicine Conference
ID
853098
Dates
17 Mar 2017 - 20 Mar 2017
Location
Cancun, United Kingdom
Abstract
Join us for the 2nd Personalized Medicine conference taking place from 17-20 March 2017 in Cancun, Mexico to discuss to discuss precision diagnostics, cancer genomics, biomarkers, computational imaging, bioinformatics and data analytics/big data. The personalized medicine space has been defined by recent regulatory approvals of targeted therapeutics in oncology and co-developed diagnostics used in patient selection. However, a broader view of personalized medicine encompasses other disease areas, newer therapeutic regimens, new therapeutic platforms and broad computational approaches. This conference will weave together many of these new approaches and their relevance to personalized medicine.
Contact
Laura Trundle;     Phone: [+44 (0) 1638724137];     Email: laura@fusion-conferences.com
Topics
precision diagnostics, cancer genomics, biomarkers, computational imaging, bioinformatics and data analytics/big data.
Related subject(s)
39.
 
Keystone Symposia - Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity
ID
825224
Dates
19 Mar 2017 - 22 Mar 2017
Location
Tahoe City, California, United States
Abstract
There are fundamental aspects of metabolic homeostasis that are regulated differently in males and females, and influence both the development of diabetes and obesity and the response to pharmacological intervention. Still, most preclinical researchers avoid studying female rodents due to the added complexity of research plans. The consequence is the generation of data that risks being relevant to only half of the population. This is a timely moment to study sex differences in diseases as NIH leadership has asked scientists to consider sex as a biological variable in preclinical research, to ensure that women get the same benefit of medical research as men. The goal of this meeting is to fill a need in the scientific community by connecting interdisciplinary groups of scientists who normally would not have an opportunity to interact. This group includes investigators studying sex differences, the role of sex hormones, the systems biology of sex and the genetic contribution of sex chromosomes to metabolic homeostasis and diseases. Leaders of the pharmaceutical industry will present their views on sex-specific drug discovery. The meeting is expected to generate new knowledge and ideas on the importance of gender biology and medicine from a molecular standpoint to the population level, and to provide the methods to study them. It is intended to be a catalyst of a process that will lead to gender-specific treatments of metabolic diseases.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
sex, gender, metabolic homeostasis, diabetes, obesity, sex differences, estrogens, androgen, drug design, gender-specific medicine, metabolomics, genetics
Related subject(s)
40.
 
Keystone Symposia - Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology
ID
825241
Dates
19 Mar 2017 - 23 Mar 2017
Location
Whistler, British Columbia, Canada
Abstract
The fields of cancer immunology and immunotherapy continue to make great strides in providing both a comprehensive understanding of the basic mechanisms underlying tumor-immune system interactions and applying this knowledge to the development of effective immune-based cancer therapies. This Keystone Symposia meeting is organized to highlight recent insights into the complex roles of immune components and pathways in controlling or alternatively promoting cancer and to showcase recent uses of cancer vaccines, checkpoint blocking strategies, adoptive cell therapies and cellular engineering approaches, either as mono- or combinatorial therapies, that have resulted in durable, effective and safe therapeutic responses to an increasing number of cancer patients. Part of the meeting will also focus on new, developing technologies that are likely to expand our capacity to monitor the effects of cancer immunotherapy with a precision, refinement and at a level that has not been possible in the past.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
cancer immunology, cancer immunotherapy, immunosuppressive cells, tumor microenvironment, immune checkpoints, combinatorial approaches, cancer vaccines, inflammation, cellular engineering, nex-gen technologies
Related subject(s)
41.
 
ITOC4 — 4th ImmunoTherapy of Cancer Conference
ID
848842
Dates
20 Mar 2017 - 22 Mar 2017
Location
Prague, Czech Republic
Abstract
The ITOC series of conferences is the premier meeting for education, scientific exchange and networking within cancer immunotherapy. The fourth edition (ITOC4) will take place on Prague, Czech Republic, from 20 to 22 March 2017. It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research. The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.
Contact
Catherine Tomek (Congress Office);     Phone: [+431405138318];     Email: itoc@medacad.org
Topics
Preclinical models, Co-stimulatory agonists and co-inhibitory antagonists, Immunogenomics, Therapeutic modulation of immune checkpoints, Combination therapy, Anti-cancer vaccines, Engineered T-cell therapy, Monitoring of immunotherapy
Related subject(s)
42.
 
8th Annual Biotherapeutics Analytical Summit
ID
829761
Dates
20 Mar 2017 - 23 Mar 2017
Location
Bethesda, United States
Abstract
Today’s complex biologics formats and ever increasing regulatory demands necessitates that companies come up with the most efficient, accurate and robust analytical methods to characterize a molecule; find the most effective tools to assess the molecule’s physico-chemical properties to optimize its druggability and developability, and to ensure that the end product is consistently safe and efficacious when comparing between batches or between biosimilars and innovators. When it comes to batch-to-batch variation, as the saying goes, “process is the product” – process analytics and quality control are thus of biggest concern to manufacturers and regulators alike.
Contact
Bethany Gray;     Phone: [781-972-5400];     Email: chi@healthtech.com
43.
 
Chemical Development & Scale-Up in the Fine Chemical and Pharmaceutical Industries
ID
858620
Dates
21 Mar 2017 - 23 Mar 2017
Location
Nice , France
44.
 
CMC Documentation & Post-Approval Changes/Variations
ID
854609
Dates
22 Mar 2017 - 23 Mar 2017
Location
Frankfurt, NH Frankfurt Niederrad, Germany
Abstract
Do you work in regulatory affairs/CMC or quality assurance? Then you shouldn’t miss out on this event. This conference will address very practical questions and provide strategic information on future CMC trends. Join the in-depth discussion on new developments, including: requirements for drug substance and drug product, elemental impurities and stability, ASMF worksharing, GMP inspection and QP declaration, quality documentation of IMPs, quality risk management, management of post-approval CMC changes and much more.
Contact
Laura Vogelmann;     Phone: [+49 6221 500-655];     Email: l.vogelmann@forum-institut.de
Topics
quality management, regulatory affairs, vigilance, drug substance and drug product in Module 3, how to implement ICH Q3D?, ASMF worksharing, QP declaration and GMP inspection, post-approval change management, CMC part of the IMPD
45.
 
CSS 2017 — Cool Supply System & Solutions 400+ 6th Annual Meeting 2017
ID
854224
Dates
23 Mar 2017 - 24 Mar 2017
Location
Brussels, Belgium
Abstract
Over 400 attendees at the GDP Brussels Cool Chain conference, 6th annual meeting time and temperature pharma controlled logistics.
Contact
Jessica Dobson;     Phone: [+44 (0) 207 096 1152];     Email: Jessica.dosbson@businessdialogue.net
Topics
time and temperature, drug sensitive logistics, thermal packaging passive active, pharmaceutical logistics, logistics in pharmaceutical industry, reverse logistics in pharmaceutical industry, pharma distribution, pharma transport, cool chain logistics, European Cool chain conference 2017 Frankfurt Cool chain conference, IQPC Arena Cool chain conference, Brussels Cool Chain 2017, CSS 2017, Pharmaceutical supply chain conference, Drug Distribution, Last mile Movianto, Temperature controlled shipment, Pharma shippers Validation, Transport Pharma validation, Pharma logistics Brussels Airport, IATA CEIV Pharma Handling Validate, Good Distribution Practice Event, Pharma EU GDP conference, GDP quality system management, management review and monitoring of medicinal logistics, Pharma logistics quality risk management, the role of qualified person, validation of containers, qualification of storage or thermal mapping, Pharma 3pl, falsified medicinal products, drug integrity, Cool Chain Europe 2017
46.
 
Keystone Symposia - HIV Vaccines
ID
825269
Dates
26 Mar 2017 - 30 Mar 2017
Location
Steamboat Springs, Colorado, United States
Abstract
Despite great progress in preventing and treating HIV, new infections continue to plague communities around the world, and the need for an HIV vaccine is as urgent as ever. Several large cohorts of HIV-infected individuals have enabled tremendous advances over the past five years in understanding immune responses to natural HIV infection. These advances have included the isolation of broad and potent anti-HIV antibodies, defining their developmental pathways, the generation of native-like Env trimers for immunization, and high-resolution structures of the envelope glycoprotein in complex with bnAbs. By 2017, many of these discoveries will have enabled new concepts to transition into human clinical trials, including passive monoclonal antibody therapy and novel immunization approaches. These platforms, incorporating improved technology for monitoring immune responses, will drive major advances in the vaccine field. This HIV Vaccines meeting will present the latest results from human clinical studies, along with the cutting-edge basic science behind such trials to highlight approaches that may lead to an HIV vaccine, and also reveal the molecular underpinnings of B and T cell-mediated immunity.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
HIV Vaccines, HIV, natural infection, transmission biology, immunogen platforms, b-cells, t-cells,
Related subject(s)
47.
 
Drug Discovery 2017 — Drug Discovery 2017
ID
853283
Dates
27 Mar 2017 - 28 Mar 2017
Location
London, United Kingdom
Abstract
The conference aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges. Highlights include: discussions on the use of CRISPR/Cas9 Technology in target discovery, hit finding and translational studies; optimising the success of phenotyping screening; exploring whether translational medicine is capable of increasing success rate in pharma; insights into receptor activation from agonist and antagonist structures; and applications of enabling chemistry technology to the acceleration of the drug discovery process. Speakers include Sanofi, Takeda, AstraZeneca, Merck Serono, Novartis, AbbVie, GSK, Johnson & Johnson, UCB Pharma, Eli Lilly & Co and more. Register at http://www.drug-discovery.co.uk/coms
Contact
Honey de Gracia;     Email: hdegracia@smi-online.co.uk
Topics
drug discovery, drug development, stem cells, precise-genome editing, CRISPR/Cas9, phenotypic screening, translational medicine, receptor activation, agonist structures, drug design, computer aided drug design, fragment based drug design, SBDD, FBDD, CADD
48.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864109
Dates
29 Mar 2017 - 31 Mar 2017
Location
London, United Kingdom
49.
 
ICBMB 2017 International Conference on Biochemistry and Molecular Biology 3-5 April 2017, Munich, Germany
ID
853095
Dates
03 Apr 2017 - 05 Apr 2017
Location
Munich, Germany
Contact
Andrea Berg;     Phone: [adeo.office@gmail.com];     Email: adeo.office@gmail.com
Topics
biology, biochemistry, molecular biology
50.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858718
Dates
04 Apr 2017 - 06 Apr 2017
Location
Verona, Italy
51.
 
MESMAP-3 — The Third Mediterranean Symposium on Medicinal and Aromatic Plants
ID
811614
Dates
13 Apr 2017 - 16 Apr 2017
Location
Girne (Kyrenia), Cyprus, Turkey
Related subject(s)
Event website
52.
 
Pharma Tech 2017 — International Conference and Exhibition on Pharmaceutical Development and Technology
ID
828931
Dates
24 Apr 2017 - 26 Apr 2017
Location
Dubai, United Arab Emirates
Abstract
ConferenceSeries LLC is a renowned organization that organizes highly notable pharmaceutical conferences and healthcare conferences throughout the globe. ConferenceSeries LLC invites all the participants from all over the world to attend “International Conference and Exhibition on Pharmaceutical Development and Technology ”during April 24-26, 2017 Dubai, UAE.This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Pharma Tech 2017 is a latest technological platform to aid efficient drug discovery and development. These platforms range from vast chemical libraries, ultra-high throughput screening and huge genetic databases in discovery, to predictive toxicology platforms and even deep-seated knowledge of particular therapeutic areas in development. New research platforms designed to help its teams of investigators focus on a set of key strategic initiatives that will help guide their multibillion-dollar drug development program to advance new medicines that can get ahead of a disease and prevent it from taking a toll.
Contact
Mythrei Syria;     Phone: [+1-702-508-5200];     Email: pharmatech@pharmaceuticalconferences.com
Topics
Pharmaceutical Technology, Pharmaceutical Technology Conferences, Pharma Tech Meetings, Pharma Tech Symposiums, Pharma Tech Exhibitions, Pharma Tech 2017 Conferences, Pharma Tech Conferences Dubai, Pharma Tech meetings USA, Pharma Tech Conferences euro
53.
 
Pharma Strategic Alliance Management — 7th Annual Strategic Alliance Management for Pharma
ID
871449
Dates
24 Apr 2017 - 26 Apr 2017
Location
London, United Kingdom
Abstract
This marcus evans conference goes back to the fundamentals: how to structure the Alliance management internally, what are the responsibilities and roles of the Alliance function. With various types of collaborations, complex projects, it’s important for Alliance Management to be structured and to have the right tools available. We will also point out the value creation in the company and how evaluating alliances by measuring progress, bringing KPI and performance tools in the process. Structuring alliances is also to count on governance body and look at relations with steering committees, legal entities and contracts to effectively run alliances along their life cycle. The delegates will have the possibility to discuss, exchange and compare their methods but also meet various stakeholders of the life science panorama.
Contact
Constandinos Vinall;     Phone: [+357 22 849 380];     Email: ConstandinosV@marcusevanscy.com
Topics
Implement the best practices in managing alliances, Improve alliance capabilities on the full alliances portfolio, Define and document common understanding and expectations with partners, Develop a set of tools to measure performance and objectives’ alignment, Choose the right partner according to the strategy and needs, Set mutual trust and keep the relationship in good conditions, Expand Alliance management framework across the organisation, Cope with unsuccessful partnerships and termination processes
Event website
54.
 
Corvus Global Events — Digi-tech Pharma 2017
ID
850927
Dates
25 Apr 2017 - 26 Apr 2017
Location
London, United Kingdom
Abstract
Digital Pharma World 2017, will provide a platform to all its participants an opportunity to interact, share and discuss the digitalization of Pharma industry. It will allow its participants to discuss the various challenges faced, new strategies, case studies and use of innovative ideas in the field of digital pharma. Also, to stay updated on the latest trends in digital, social media and mobile strategies required the overcome the obstructions in the transformation. This conference will allow IT leaders to share their technologies and strategies to help the pharma industries. The conference will offer opportunities to encourage partnerships and collaborations
Contact
Fazmina Fajjuu;     Phone: [+44 (0) 207 096 0786];     Email: fazmina@corvusglobalevents.com
Topics
Key Highlights of the conference: • Digitally enabled business models • Big data analytics and pharma • Internet of things and pharma • Translational Informatics • Policy changes required for ensuring smooth transition • Ensuring regulatory compliance during the transformation • Digital marketing trends • Integrating Multichannel marketing and closed loop marketing • Digitalization of R& D using Big Data and IoT • New smart devices in manufacturing and supply chain • Clinical trials and digital world • Data management • Tools and strategies to engage with HCPs and patients and to win their confidence • Encouraging a customer–centric approach at all levels • Unrealized innovative potentials of digital era that pharma needs to focus on . Attendees includes VPs, GMs, Directors, Heads and Managers of • Pharma sales and Marketing • E-marketing • Digital innovative strategic planning • Regulatory and pharmacovigilance • IT consultants • Clinical trials and data management • Translational informatics • Data storage and analysis • Contract outsourcing service providers • Multi-channel Management • Health care professionals • Health IT professionals
55.
 
PFS East Coast — Pre-Filled Syringes East Coast
ID
854619
Dates
26 Apr 2017 - 27 Apr 2017
Location
Boston, United Kingdom
Abstract
Building on the success of previous sell-out shows, SMi Group is delighted to announce the return of the 4th annual conference and exhibition: Pre-Filled Syringes - East Coast, taking place on April 26th – 27th 2017 in Boston, Massachusetts, USA. Through a combination of powerful keynote addresses, topical debate and interactive workshops, Pre-Filled Syringes East Coast will once again play host to an audience of senior scientists, device manufacturers and PFS market professionals, providing a unique platform to discuss the latest innovations and developments in pre-filled syringes; as well as hone in on industry challenges and regulatory compliance. Featured speakers include AbbVie, Shire, Amgen, Eli Lilly, Allergan, Janssen, Merck and more!
Contact
Teri Arri;     Phone: [2078276000];     Email: tarri@smi-online.co.uk
Topics
prefilled syringe, pre-filled syringe, autoinjector, human factors, device development, innovation, strategy, extractables, leachables, patient safety, compliance, biosimilar, parenteral, packaging, combination products, lyophilisation, freeze drying, injectable, injectable devices, syringe, extractables and leachables, E&L, PFS, drug device, drug delivery, combination products, sterilization, needle, component, glass syringe, cop syringe, container, formulation, device development, human factors, manufacturing, device technology, medical device, parenteral drug, plastic, qbd, drug delivery
Related subject(s)
56.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864031
Dates
26 Apr 2017 - 28 Apr 2017
Location
Berlin, Germany
57.
 
Keystone Symposia - Modeling Viral Infections and Immunity
ID
825419
Dates
01 May 2017 - 04 May 2017
Location
Estes Park, Colorado, United States
Abstract
Viral infection modeling has provided insights into the pathogenesis and treatment of HIV, HCV, HSV-2, CMV and other viruses. It has had impact in revealing the lifespan of infected cells, how rapidly virus is produced and cleared from the circulation, and the means for evaluating the effectiveness of antiviral treatments. HIV remains a global health threat and there is great interest in revealing features of the main HIV reservoir, latently infected cells and mechanisms of reducing the size of this reservoir by pharmacological means. Other important gaps in knowledge revolve around the cell-mediated and humoral immune responses to HIV, important for generating vaccines and broadly neutralizing antibodies as therapeutics, topics that will be discussed. Further, viral infections generally occur in tissues and thus the meeting will discuss imaging techniques and methods of modeling and analyzing spatial infection data, the role of tissue-resident memory cells, and important features of immune regulation, such as immune exhaustion, cytokine signaling between cells, and viral subversion of innate responses and escape from adaptive responses. The meeting will highlight what we believe are significant hurdles to curing viral infections and will bring together experimental virologists, physician scientists and modelers of various types and experience, groups that do not normally meet. It should foster new collaborations between experimentalists and theoreticians, and between theoreticians working on different viral infections or different aspects of viral infections, as well as help young scientists formulate new research directions and make connections with established senior scientists.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
modeling viral infections, immunity, viral infection, Modeling Immune Regulation, HIV, Modeling Cellular Immune Responses, Spatial Aspects of Infection
Related subject(s)
58.
 
Training — Validation & Transfer of Methods for Pharmaceutical Analysis
ID
864085
Dates
03 May 2017 - 05 May 2017
Location
Dublin , Ireland
59.
 
3rd Annual Formulation & Drug Delivery Congress
ID
859530
Dates
08 May 2017 - 09 May 2017
Location
London, United Kingdom
Abstract
Oxford Global are proud to present our 2017 3rd Annual Formulation & Drug Delivery Congress, taking place on 8 – 9 May 2017 in May in London, UK. Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will have the opportunity to discuss over 40 presentations and case studies focused on the key issues in large molecule and small molecule drug formulation and drug delivery. Including 4 interactive streams: Large Molecule Drug Formulation; Small Molecule Drug Delivery; Small Molecule Drug Formulation and Large Molecule Drug Delivery.
Contact
Guillaume Alonso;     Phone: [+44 (0) 1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Topics
drug delivery, drug formulation, small molecule, large molecule
Related subject(s)
60.
 
Adverse Drug Reactions, Drug Interactions and Pharmacovigilance
ID
828826
Dates
08 May 2017 - 12 May 2017
Location
Oxford, United Kingdom
Abstract
The Adverse Drug Reactions, Drug Interactions and Pharmacovigilance course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the teaching will be led by Dr Michael Theodorakis, Radcliffe Department of Medicine, University of Oxford, and will feature face-to-face lectures and tutorials from some of the country's leading clinicians and scientists.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
61.
 
The Health Technology Assessment Course - Trends & Opportunities in Europe
ID
834335
Start date
09 May 2017
Location
Brussels, Belgium
Abstract
Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
62.
 
E&L USA 2017 — Extractables & Leachables USA 2017
ID
854349
Dates
09 May 2017 - 11 May 2017
Location
Falls Church, VA, United States
Abstract
Extractables and leachables examination is continuously growing in importance. Given the current scruitny paid by governing bodies including the FDA and EMEA, understanding the best practice and guidelines to carry out extractables and leachables studies is imperative in order to eliminate risk and potential development delays.
Contact
Emma Nweton;     Phone: [+44 (0) 1372 802016];     Email: enewton@smithers.com
Topics
extractables, leachables, analytical chemistry, pharmaceuticals, drug development, drug delivery, regulations, quality assurance, single-use systems, risk assessments, packaging, drug packaging
63.
 
Orphan Drugs and Rare Diseases Europe 2017
ID
852676
Dates
15 May 2017 - 16 May 2017
Location
Berlin, Germany
Abstract
SMi is proud to announce the return of their 6th annual Orphan Drugs event to Berlin on the 15th -16th May 2017! The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019.* With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market.
Contact
Kyra Williams;     Email: kwilliams@smi-online.co.uk
Topics
Orphan Drugs, Rare Diseases, Market Access, Pricing and Reimbursement, Patient Recruitment
64.
 
Gavin Conferences — International Conference on Pharmaceutical Drugs
ID
848206
Dates
15 May 2017 - 17 May 2017
Location
Dubai, United Arab Emirates
Abstract
Gavin Conferences invites participants from all over the world to attend “International Conference on Pharmaceutical Drugs” to be held on May 15-17, 2017 at Dubai, UAE. The conference is organized with the theme “Bridging the gap between Drugs and Disease Prevention” which includes keynote presentations from world class scientists and researchers, Oral talks, Poster presentations, B2B meetings and Exhibitions. World-renowned speakers, the most recent techniques and updates in the field of Pharmaceutics are hallmarks of this conference.
Contact
Daniel;     Phone: [6303970234];     Email: danielgavin456@gmail.com
Topics
Pharmaceutical Drug Development,  Drug Formulation, Evaluation, Drug Discovery, Drug Designing, Drug Delivery Systems, New Manufacturing technologies, Pharmaceutical Industry, Adverse Drug Reactions, Pharmaceutical Business
65.
 
MENA Cold Chain — 4th Annual MENA Pharmaceutical Cold Chain Forum
ID
870063
Dates
16 May 2017 - 17 May 2017
Location
Dubai, United Arab Emirates
Abstract
The MENA region continues to face its challenges as most temperature deviations occur during supply chain transportation. The pharmaceutical industry relies heavily on the airline industry for its speed and efficiency. Unfortunately, 57% of deviations happen at the airport premises. Temperature changes during transportation have been a serious threat to the integrity of the products. Shippers in the region are on a constant look out for service providers who can help them maintain the product integrity and efficacy during transportation.
Contact
MCI Dubai;     Phone: [97143116300];     Email: conferences@mci-group.com
Topics
Pharmaceutical
66.
 
Principles of Pharma Market Access in Europe
ID
834261
Dates
16 May 2017 - 17 May 2017
Location
Zurich, Switzerland
Abstract
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
67.
 
Value Pricing for Market Access - The Fundamentals
ID
834333
Dates
18 May 2017 - 19 May 2017
Location
Zurich, Switzerland
Abstract
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
68.
 
HPAPI — Highly Potent Active Pharmaceutical Ingredients (HPAPI) 2017
ID
854654
Dates
22 May 2017 - 23 May 2017
Location
London, United Kingdom
Abstract
The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs. However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions. This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find innovative new solutions.
Contact
Kyra Williams;     Email: kwilliams@smi-online.co.uk
Topics
API- Active Pharmaceutical Ingredients, Cytoxic, Potency, HA - Health Agency, PDE - Permitted Daily Exposure, Cross Contamination, Compound, Scale Up
Related subject(s)
Event website
69.
 
Biologistics World Korea 2017
ID
827197
Dates
23 May 2017 - 24 May 2017
Location
Seoul, South Korea
Abstract
Biologistics World Korea is the MOST Targeted event in Korea that focuses on supply chain management and logistics for biologics and vaccines. Located in Singapore, the prime logistics hub of Korea, the programme promises to bring together key opinion leaders, rising players and market experts to discuss, debate and brainstorm on the most pertinent issues affecting Korea’s logistics network within a global context!
Contact
Andrew Darwitan;     Phone: [+65 3109 0156];     Email: andrew.darwitan@imapac.com
70.
 
Learning and Memory: Cellular and Molecular Mechanisms
ID
857955
Dates
28 May 2017 - 04 Jun 2017
Location
Siena, Italy
Abstract
Recent ground-breaking developments in neuroscience, such as optogenetics, in vivo 2-photon confocal microscopy, head mounted microscopes, powerful new developments in modeling, behavioral neuroscience approaches, and sophisticated brain imaging tools, have changed dramatically studies of memory. Most importantly, these developments have fostered interdisciplinary studies that led to integrated molecular, cellular, systems, cognitive and behavioral explanations of how memories are allocated, formed, consolidated, reconsolidated and retrieved. These studies have also led to mechanistic cross-disciplinary studies of memory disorders, which in some cases led to the development of targeted treatments that are changing how we imagine treating the considerable health burden associated with this large class of conditions.
Contact
Francesca Martini;     Phone: [+39.0577.146.0003];     Email: info@nsas.it
Related subject(s)
71.
 
18th Annual Drug Discovery Summit
ID
845378
Dates
12 Jun 2017 - 13 Jun 2017
Location
Berlin, Germany
Abstract
This summit brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective enabling technologies and solutions. Our co-located 5th Discovery Chemistry & Drug Design Congress provides an unprecedented opportunity to gain insights from key presenters of the computational chemistry, discovery chemistry and medicinal field.
Contact
Guillaume Alonso;     Phone: [+44 (0) 1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Topics
drug discovery, screening, genomics, biotechnology, pharmaceutical, small molecule, large molecule, technologies
72.
 
Pharma Engineering 2017 — International Conference on Pharmaceutical and Biomedical Engineering
ID
852611
Dates
12 Jun 2017 - 13 Jun 2017
Location
Taipei, Taiwan
Abstract
Conference Series LLC is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth “International Conference on Pharmaceutical and Biomedical Engineering” (Pharma Engineering 2017) scheduled to be held during June 12-13, 2017 at Taipei, Taiwan. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical and Biomedical Engineering.
Contact
Diya Sharan;     Phone: [7025085200];     Email: pharmaengineering@pharmaceuticalconferences.com
Topics
Pharmaceutical Engineering, Biomedical Engineering, Pharmaceutical Technology, Pharmaceutical Formulations, Drug delivery, Drug Discovery, Genetic Engineering, Tissue Engineering, Bio Imaging, Process Engineering, Pharmaceutical Process Technology Novel drug deliveryNanotechnology Engineering
73.
 
10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
ID
831645
Dates
13 Jun 2017 - 15 Jun 2017
Location
London, United Kingdom
Contact
Renaldo Hawell;     Email: renaldohowell179@gmail.com
Topics
Pharmaceutics/Formulation/Drug Delivery/Vaccine/Novel Drug Delivery
74.
 
Chemical Development & Scale-Up in the Fine Chemical and Pharmaceutical Industries
ID
858741
Dates
13 Jun 2017 - 15 Jun 2017
Location
Edinburgh , United Kingdom
75.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858806
Dates
13 Jun 2017 - 15 Jun 2017
Location
Chicago, United States
76.
 
Training — Validation & Transfer of Methods for Pharmaceutical Analysis
ID
864084
Dates
14 Jun 2017 - 16 Jun 2017
Location
London, United Kingdom
77.
 
FASEB SRC — From Unfolded Proteins in the Endoplasmic Reticulum (ER) to Disease
ID
871044
Dates
18 Jun 2017 - 23 Jun 2017
Location
Saxtons River, VT, United States
Abstract
This SRC focuses on the endoplasmic reticulum (ER) and its functions. The purpose of the meeting is to merge recent developments in molecular biology, cell biology, genetics, and physiology aimed at unraveling the complexities of secretory protein folding, ER stress pathways, lipid signaling, and ER membrane biology, and how failure of these processes lead to pathologies and disease. This SRC will include talks from outstanding scientists, both invited and selected from poster abstracts. The meeting is known for its active discussions, not only during the presentation session, but also during the free afternoons, and especially during the poster sessions. Posters will remain on display during most of the conference and a selection will be advertised in oral poster pitches. The venue, Vermont Academy, is excellently suited for the mingling of junior and established scientists, which will be strengthened by meet-the-speaker sessions that allow discussions of both career issues and science.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics
biochemistry, Pharmacology
Related subject(s)
78.
 
Health Economics for Non-Health-Economists
ID
834351
Dates
20 Jun 2017 - 21 Jun 2017
Location
Brussels, Belgium
Abstract
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
79.
 
Antibodies & Complement: Effector Functions, Therapies & Technologies
ID
781857
Dates
20 Jun 2017 - 23 Jun 2017
Location
Albufeira, Portugal
Abstract
The antibody response and the complement system are major effector arms of the immune system. Both have been involved in a plethora of pathological conditions – including autoimmunity, allergy, infections and cancer- and regulate, mainly through their receptors (FcR and CR respectively) cell activation, migration, survival but also metabolism. As the portfolio of antibody- and complement-effector function grow, high-end technological solutions are developed and novel therapeutic applications are proposed.

This Zing conference will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts.

Related subject(s)
80.
 
16th Annual Medicinal & Pharmaceutical Sciences Congress (Med Pharma Congress)
ID
852325
Dates
03 Jul 2017 - 05 Jul 2017
Location
Kuala Lumpur, Malaysia
Abstract
Conference Series LLC invites all the participants across the globe to attend 16th Annual Medicinal & Pharmaceutical Sciences Congress during July 3-5, 2017 in Kuala Lumpur, Malaysia which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Med Pharma Congress is a specially designed cluster Pharma conference. The main theme of this Pharma conferences is “Developing the Synergy between Pharmaceutics and Medicinal Chemistry to Deliver Better Drugs” which covers a wide range of critically important sessions.
Topics
Medicinal Chemistry • Pharmacology • Chromatographic Techniques for Drug Analysis • Synthetic Organic Chemistry • Bio Pharmaceuticals • Pharmacogenomics • Pharmacognosy and Phytochemistry • Pharmaceutical Toxicology • Industrial Pharmacy
Related subject(s)
81.
 
How to do Research on Therapeutic Interventions: Protocol Preparation
ID
828710
Dates
03 Jul 2017 - 07 Jul 2017
Location
Oxford, United Kingdom
Abstract
The How to do Research on Therapeutic Interventions: Protocol Preparation course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the teaching will be led by Dr Grant D Vallance, Information Manager at the Oxford University Hospitals NHS Trust, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
82.
 
9th World Congress on BA/BE Studies and Biowaivers
ID
849785
Dates
17 Jul 2017 - 19 Jul 2017
Location
Melbourne, Australia
Abstract
Bioequivalence Congress is a 3-day event offering the Exhibition, at venue to showcase the new and emerging technologies and have wider sessions involving Keynote presentation, Oral, YRF ( student presentation), poster, e-poster presentations. World-renowned speakers and eminent delegates across the globe attending the conference, to share their valuable presentation on the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.
Contact
Daisy Pearl;     Phone: [(702) 508-5200 Extn-8045];     Email: ba.beasia@pharmaceuticalconferences.org
Topics
drug research, generic drugs, bioequivalence, pharmacology, clinical pharmacology, bcs, biowaivers, pharmcodynamic studies, clinical trails, clinical research, FDA
83.
 
9th International Conference and Exhibition on Pharmacovigilance & Drug Safety
ID
869819
Dates
17 Jul 2017 - 19 Jul 2017
Location
Munich, United States
Contact
programe cordinator;     Phone: [702-508-5200];     Email: pharmacovigilance@pharmaceuticalconferences.org
Topics
Advanced Regulatory Compliance in Pharmacovigilance operations and innovations Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
84.
 
NanoPharma 2017 — 13th International Conference and Exhibition on Pharmaceutical Nanotechnology
ID
852381
Dates
24 Jul 2017 - 25 Jul 2017
Location
Rome, Italy
Abstract
Currently we are bringing forth “13th International Conference and Exhibition on Pharmaceutical Nanotechnology” (NanoPharma 2017) scheduled to be held during July 24-25, 2017 at Rome, Italy. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Nanotechnology and Drug delivery.
Contact
Angela Mathews;     Phone: [7025085200];     Email: nanopharma@pharmaceuticalconferences.org
Topics
drug delivery, nanoparticles, nanodrugs, nanomedicines, nanopharmaceuticals, pharmaceutical nanotechnology, liposomes, neosomes, erythrosomes
85.
 
Asia Pharma 2017 — 10th Asia-Pacific Pharma Congress
ID
827401
Dates
24 Jul 2017 - 26 Jul 2017
Location
Melbourne, Australia
Abstract
Asia Pharma 2017 is a perfect platform for scientists, decision-makers and students to come together, compare findings, and discuss the science of the future. Share your research with an engaged audience of your peers from around the globe; learn from scientific trail blazers who are designing more sustainable processes; find out how Pharmaceutical innovations are inspiring new businesses and product lines. Pharmaceutical sciences focus on the physiology and chemistry controlling drug therapeutic action in modern medicine. Often confused with pharmacy practice, pharmaceutics is distinct in its research and development emphasis, contributing important technologies and scientific bases for drug delivery to patients. Over half of newly discovered drug candidates cannot be commercialized without further drug delivery and formulation assistance. Researchers trained in pharmaceutics integrate a broad working knowledge of diverse scientific disciplines: from fundamental studies of drug physiochemical properties and bioactive molecules to mechanisms of various physiological processes that impact drug delivery to specific biological sites of action and, therefore, their therapeutic effectiveness. Increasing awareness of the complexity of the drug delivery process in living systems means that researchers in pharmaceutics today must maintain breadth and depth in physical chemistry, physical organic chemistry, bioengineering, nanotechnology and the life sciences in order to solve research problems that require integration basic science concepts from multiple disciplines with medical applications.
Contact
Robert Brown;     Phone: [17025085200];     Email: asiapharma@pharmaceuticalconferences.com
Topics
Regulatory Affairs, Intellectual Property Rights, Pharmacognosy and Phytochemistry, Advancements in Pharmaceutics, Trends in Nanotechnology, Industrial Pharmacy, Pharmacological Studies, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutical Microbiology, Pharmaceutical Biotechnology, Biochemistry and Molecular Biology, Clinical Pharmacy, Hospital Pharmacy, Pharmaceutical Care & Health Systems, Pharma Compliance.
86.
 
International Vaccines Congress
ID
857224
Dates
27 Jul 2017 - 28 Jul 2017
Location
Chicago, United States
Abstract
PULSUS is the publisher of peer reviewed scientific, technical, and medical journals and magazines. Since establishment 1984, has been instrumental in healthcare and medical dissemination. PULSUS expanded with the support from scientific societies and open its arm to conduct global medical and healthcare meetings. With immense please and support, PULSUS is honored to announced it International Vaccines Congress, which will be going to held in Chicago, USA during July 27-28, 2017.
Contact
Annah Brwon;     Email: vaccinescongress@protonmail.com
Topics
vaccines Congress, Vaccines Conference 2017, Vaccines Conference USA
Related subject(s)
87.
 
Pharmacology Studies 2017 — International Conference on Pharmacology & Toxicology Studies
ID
859584
Dates
07 Aug 2017 - 09 Aug 2017
Location
Philadelphia, United States
Abstract
Scientific Synergy Conferences are delighted to welcome you all to the
Contact
Scientific Synergy;     Phone: [+1-888-623-5051];     Email: pharmacology@scientificsynergy.com
Topics
Pharmacology Studies 2017, Pharmacology Conference, Toxicology Conference, Scientific Synergy USA, Pharmacology Conference Philadelphia, Pharmacology Congress USA, Clinical Pharmacology event, Drug Toxicology, Pharmacology Case Reports, Forensic Toxicology.
88.
 
Biosimilars Asia 2017 — 8th Asian Biosimilars Congress
ID
841178
Dates
14 Aug 2017 - 16 Aug 2017
Location
Osaka, Japan
Abstract
Biosimilars Asia 2017 is a specially designed cluster conference. The main theme of the conference is
Contact
Victorya Jones;     Phone: [7025085200];     Email: biosimilarsasia@pharmaceuticalconferences.com
Topics
biosimilars, biologics, biosimilars conference, biologics conferences, biosimilars events, Biologics events, biosimilars workshops
89.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858834
Dates
11 Sep 2017 - 13 Sep 2017
Location
Clarion Hotel Prague, Czech Republic
90.
 
Formulation & Drug Delivery USA Congress
ID
871360
Dates
14 Sep 2017 - 15 Sep 2017
Location
Boston, United States
Abstract
Oxford Global are proud to present our Formulation & Drug Delivery USA Congress, taking place on 14 – 15 September 2017 in Boston. Over 150 delegates representing leading pharmaceutical organisations, biotech companies and internationally renowned research & academic institutions will be present to discuss and network. Over 40 case studies and presentations focused on exploring regulatory guidelines of both large and small molecule formulations, future applications of protein and peptide formulations, recent advancements in nanoparticles as drug delivery systems, combination drug delivery devices and improving the bioavailability of compounds.
Contact
Guillaume Alonso;     Phone: [+44 (0) 1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Topics
drug formulation, drug delivery, small molecules, large molecules
91.
 
Training — Validation & Transfer of Methods for Pharmaceutical Analysis
ID
864127
Dates
27 Sep 2017 - 29 Sep 2017
Location
Berlin, Germany
92.
 
Principles of Pharma Market Access in Europe
ID
834315
Dates
03 Oct 2017 - 04 Oct 2017
Location
Brussels, Belgium
Abstract
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
93.
 
Value Pricing for Market Access - The Fundamentals
ID
834354
Dates
05 Oct 2017 - 06 Oct 2017
Location
Brussels, Belgium
Abstract
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
94.
 
Safety & Selectivity in the Scale-Up of Chemical Reactions
ID
858843
Dates
09 Oct 2017 - 10 Oct 2017
Location
Lisbon , Portugal
95.
 
Scaling from Milligrams to 1-2kg: Making the First GMP Batch
ID
858853
Dates
09 Oct 2017 - 10 Oct 2017
Location
Lisbon , Portugal
96.
 
Chemical Development & Scale-Up in the Fine Chemical and Pharmaceutical Industries
ID
858918
Dates
11 Oct 2017 - 13 Oct 2017
Location
Lisbon , Portugal
97.
 
Health Economics for Non-Health-Economists
ID
834438
Dates
12 Oct 2017 - 13 Oct 2017
Location
Zurich, Switzerland
Abstract
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
98.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864159
Dates
18 Oct 2017 - 20 Oct 2017
Location
London, United Kingdom
99.
 
MedTechConf Sarajevo
ID
868399
Dates
19 Oct 2017 - 20 Oct 2017
Location
Sarajevo, Bosnia and Herzegovina
Contact
Edina Musmulja;     Phone: [+ 387 61 914 178];     Email: info@medtechconf.com
Topics
Regenerative Medicine & Biological Materials, Future Drugs, Three-dimensional Echocardiography, Neuroscience, Health Economics, Artificial Intelligence & New Technology Development, Future Healthcare Ecosystems & Medical Billing
100.
 
ICCP — 5th International Conference on Clinical Pharmacy
ID
858226
Dates
23 Oct 2017 - 24 Oct 2017
Location
Florida, United States
Abstract
Clinical Pharmacy Conference aims to bring together leading academic scientists, researchers, and research scholars to exchange and share their experiences and research results about all aspects of Clinical Pharmacy. It also provides the disciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Clinical Pharmacy. All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers, and e-posters. Also, high-quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Clinical Pharmacy are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers, and e-posters that address themes and topics of the conference, including figures, tables, and references of novel research material. The conference abstracts and proceedings book and certificate of presentation will be distributed to the conference participants at the conference registration desk. In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of biomedical, pharmaceutical, and clinical sciences by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects of Clinical Pharmacy.
Contact
Victor Badoni;     Phone: [7025085200 Ext: 8047];     Email: badonivictor@outlook.com
Topics
Pharma Conferences, Pharmacy Conferences, Clinical Pharmacy Conferneces, Pharmaceutical Conferences
101.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858873
Dates
31 Oct 2017 - 02 Nov 2017
Location
Boston , United States
102.
 
Biomarkers congress 2017 — Annual World Congress on Biomarkers & Clinical Research
ID
867784
Dates
27 Nov 2017 - 28 Nov 2017
Location
Atlanta, United States
Abstract
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its clinical researches. Listen to motivating keynotes from thought leaders, pioneers across the globe. Atlanta is all set for an amazing event as PULSUS proudly presents the “Annual World Congress on Biomarkers & Clinical Research” on November 27-28, 2017. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of BIOMARKERS from around the world to participate in the upcoming BIOMARKERS CONGRESS 2017. The meeting for this year will revolve around the theme “Explore the latest Biomarkers development in health and clinical research” thus relaying the most cutting edge findings in the field of Biomarkers Research.
Contact
Rachel Mathews;     Email: america@cmesociety.com
Topics
Biomarkers Conference, Biomarkers Conference 2017, Biomarkers Conference December, Cancer Biomarkers, Cancer Conferences, Cancer Conferences 2017, Biomarkers Events, Biomarkers Society Conferences, Biomarkers Congress
Related subject(s)
103.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864114
Dates
27 Nov 2017 - 29 Nov 2017
Location
Berlin, Ireland
104.
 
The Health Technology Assessment Course - Trends & Opportunities in Europe
ID
834378
Start date
30 Nov 2017
Location
Brussels, Belgium
Abstract
Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
105.
 
Principles of Pharma Market Access in Europe
ID
834303
Dates
05 Dec 2017 - 06 Dec 2017
Location
London, United Kingdom
Abstract
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
106.
 
Value Pricing for Market Access - The Fundamentals
ID
834408
Dates
07 Dec 2017 - 08 Dec 2017
Location
London, United Kingdom
Abstract
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
107.
 
Health Economics for Non-Health-Economists
ID
834404
Dates
14 Dec 2017 - 15 Dec 2017
Location
Brussels, Belgium
Abstract
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
108.
 
Eilat XIV — Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices
ID
839627
Dates
13 May 2018 - 16 May 2018
Location
Madrid, Spain
Abstract
Based on the success of the past thirteen Eilat Conferences on New Antiepileptic Drugs and Devices (AEDs), the Organizing Committee takes pleasure in inviting you to participate in the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV), which will take place in Madrid, Spain, May 13 - 16, 2018.

For the forthcoming conference, we will be continuing with debates as well as adhering to the format of the previous conferences which are designed to provide an in-depth progress report on new antiepileptic drugs in various stages of development, as well as to present new findings on second-generation treatments.

Contact
Vikki Hyman;     Phone: [+97235175150];     Email: eilat@target-conferences.com
Topics
epilepsy, antiepileptic, drugs, devices, treatments, conference, congress
Related subject(s)
Event website
RNA Therapeutics conference
Superbugs & Superdrugs Conference

Good to know...

You can advertise your event or services in this space.

Last updated: 21 January 2017